Clinical trial

Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy…

NCT00492011 · Takeda, Industry · Completed

Key facts

NCT number NCT00492011
Title Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers
Official title A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Ability of Ramelteon 1 mg, 4 mg, and 8 mg to Alleviate the Insomnia Symptoms Associated With Eastward Bound Jet Lag Across 5 Time Zones in Healthy Adult Volunteers
Lead sponsor Takeda, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Circadian Dysregulation
Intervention type Drug
Interventions Ramelteon, Placebo
Enrollment 110
Start date Feb 1, 2007
Primary completion Aug 1, 2007
Completion Aug 1, 2007
First posted Jun 27, 2007
Last update posted Feb 28, 2012
Countries United States

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies